跳至主要内容
临床试验/NCT07308678
NCT07308678已完成不适用

Wound Closure in Venous Leg Ulcers (VLUs) Treated With AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®: A Blinded Re-Assessment of Randomized Controlled Trial Findings

ConvaTec Inc.1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2025年4月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
ConvaTec Inc.
入组人数
105
试验地点
1
主要终点
Wound closure at 12 weeks

研究概览

简要总结

Study is to provide a blinded assessment of wound closure status utilizing photographs collected as per standard of care (SOC) during the AAA RCT (WC-22-435).

详细描述

The purpose of the study is to provide a blinded (treatment arm, timepoint) assessment of wound closure status utilizing photographs collected as per standard of care (SOC) during the AAA Randomized Controlled Trial (RCT) (WC-22-435).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All subjects from the intention to treat (ITT) population with wound photograph(s) corresponding to the study visit date (WC-22-435) indicating wound closure or their 12-week visit, whichever came first

排除标准

  • Subjects whose photographs are deemed of insufficient quality to make determination of closure

结局指标

主要结局

Wound closure at 12 weeks

时间窗: 12 week

Incidence of wound closure at 12 weeks, defined as 100% epithelialization of the wound surface, assessed by a blinded observer through photographic evidence

次要结局

未报告次要终点

研究者

发起方
ConvaTec Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验